Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000921895-19-000047
Filing Date
2019-01-09
Accepted
2019-01-09 20:49:06
Documents
1
Period of Report
2018-04-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form4105735001_01092019.html 4  
1 OWNERSHIP DOCUMENT form4105735001_01092019.xml 4 52673
  Complete submission text file 0000921895-19-000047.txt   55421
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020
Business Address
COUCHMAN JONATHAN (Reporting) CIK: 0001265094 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36435 | Film No.: 19519131

Mailing Address 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020
Business Address 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020 212.729.4962
Xstelos Corp. (Reporting) CIK: 0001571659 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-36435 | Film No.: 19519133

Mailing Address 630 FIFTH AVENUE, SUITE 2260 NEW YORK NY 10020
Business Address 630 FIFTH AVENUE, SUITE 2260 NEW YORK NY 10020 (212) 729-4962
Couchman Family Fund (Reporting) CIK: 0001737322 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36435 | Film No.: 19519132